Tower Research Capital LLC (Trc) Ambrx Biopharma Inc. Transaction History

Tower Research Capital LLC (Trc)

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$9.3 - $16.6 $2,185 - $3,901	235 New	235 $2,000
Q1 2023 May 09, 2023	BUY	$1.46 - $12.54 $29,838 - $256,279	20,437 Added 681233.31%	20,440 $182,000
Q4 2022 Feb 10, 2023	SELL	$0.41 - $4.54 $15 - $177	-39 Reduced 92.86%	3 $0
Q3 2022 Nov 10, 2022	BUY	$1.06 - $2.96 $44 - $124	42 New	42 $0

31.2K

Ticker AMAM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,618,400
Market Cap $1.08B
Description
Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gas...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.